FDA Approved: EYLEA — Original Application (Regeneron Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved EYLEA (aflibercept) through its original application, establishing its initial indications for retinal diseases including age-related macular d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Macular Edema Following Retinal Vein Occlusion

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

ORIG AP for EYLEA (AFLIBERCEPT)